c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers.

被引：0
|
作者：
Tsuta, K. [1 ]
Yoshida, A. [1 ]
Tsuda, H. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1812
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [31] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Caixia Ding
    Yanyi Qiu
    Juan Zhang
    Wei Wei
    Hongbian Gao
    Yong Yuan
    Xiaomin Wang
    BMC Pulmonary Medicine, 23
  • [32] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Ding, Caixia
    Qiu, Yanyi
    Zhang, Juan
    Wei, Wei
    Gao, Hongbian
    Yuan, Yong
    Wang, Xiaomin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [33] Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer
    Xu, Chun-wei
    Wang, Wen-xian
    Wu, Mei-juan
    Zhu, You-cai
    Zhuang, Wu
    Lin, Gen
    Du, Kai-qi
    Huang, Yun-jian
    Chen, Yan-ping
    Chen, Gang
    Fang, Mei-yu
    THORACIC CANCER, 2017, 8 (05) : 417 - 422
  • [34] EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer
    Crees, Zachary D.
    Shearrow, Caleb
    Lin, Leo
    Girard, Jennifer
    Arasi, Kavin
    Bhoraskar, Aayush
    Berei, Joseph
    Eckburg, Adam
    Anderson, Austin D.
    Garcia, Christian
    Munger, Ariana
    Palani, Sunil
    Smith, Thomas J.
    Sreenivassappa, Shylendra B.
    Vitali, Connie
    David, Odile
    Puri, Neelu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [35] Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
    Yilmaz, Ahmet
    Mohamed, Nehad
    Patterson, Kara A.
    Tang, Yan
    Shilo, Konstantin
    Villalona-Calero, Miguel A.
    Davis, Michael E.
    Zhou, Xiaoping
    Frankel, Wendy
    Otterson, Gregory A.
    Beall, Howard D.
    Zhao, Weiqiang
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2014, 11 (09) : 9491 - 9502
  • [36] Association Between PD-L1 Expression and c-Met Alterations in Non-Small Cell Lung Carcinoma
    Tenney, Troy
    Sica, Gabriel
    Saxe, Debra
    Owonikoko, Taofeek
    Ramalingam, Suresh
    Zhang, Linsheng
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1821 - 1821
  • [37] Association Between PD-L1 Expression and c-Met Alterations in Non-Small Cell Lung Carcinoma
    Tenney, Troy
    Sica, Gabriel
    Saxe, Debra
    Owonikoko, Taofeek
    Ramalingam, Suresh
    Zhang, Linsheng
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1821 - 1821
  • [38] A MET Inhibitor in the Treatment of Metastatic Non-Small Cell Lung Cancer with MET Amplification
    Zhang, Tongtong
    Li, Junling
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S236 - S236
  • [39] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
    Liang, Hongge
    Wang, Mengzhao
    ONCOTARGETS AND THERAPY, 2020, 13 : 2491 - 2510
  • [40] Palliative resections in patients with non-small cell lung cancers. Burden or benefit?
    Striessnig, Anneliese
    Gschwandtner, Elisabeth
    Zettl, Richard
    Lindenmann, Joerg
    Fink-Neuboeck, Nicole
    Fediuk, Melanie
    Maier, Alfred
    Smolle-Juettner, Freyja-Maria
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (19-20) : 775 - 775
12345